MedTrace Logo

Metaverse-Based Healthy Life Program for Youth

NCT05332886 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2022-04-18

No results posted yet for this study

Summary

This study was planned within the scope of the call titled "Non-communicable diseases risk reduction in adolescence and youth (Global Alliance for Chronic Diseases - GACD)" with identity number HORIZON-HLTH-2022-DISEASE-07-03. The purpose of this project; is to determine the effect of the Metaverse-Based Healthy Life Program to be developed in the project to support youths in decreasing future risks of developing non-communicable diseases (NCDs) and in gaining healthy lifestyle behaviors (HLBs).

Conditions

  • Health Risk Behaviors
  • Healthy Lifestyle
  • Non Communicable Diseases
  • Health-Related Behavior
  • Healthy Eating Index
  • Healthy Nutrition
  • Physical Inactivity
  • Stress, Emotional

Interventions

BEHAVIORAL

MetaHealth Group

Three metaverse rooms will be created via metaverse technology that aims to develop healthy nutrition, physical activity, and psychological resilience skills to reduce the risk of of NCDs in youth.

BEHAVIORAL

MobileHealth Group

The intervention aims to develop healthy nutrition, physical activity, and psychological resilience skills using mobile application materials to reduce the risk of NCDs in youth.

Sponsors & Collaborators

  • Horizon

    collaborator INDUSTRY

  • Ayşegül İşler Dalgıç

    lead OTHER

Principal Investigators

  • Ayşegül İşler Dalgıç, Professor · Akdeniz University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2025-03-01
Completion
2025-05-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05332886 on ClinicalTrials.gov